Détail du document
Identifiant

doi:10.1038/s42003-023-05757-3...

Auteur
Cao, Yan Li, Jian Zhang, Gang Fang, Hao Du, Yongliang Liang, Yan
Langue
en
Editeur

Nature

Catégorie

Life Sciences

Année

2024

Date de référencement

31/01/2024

Mots clés
colorectal ptbp1 cancer klf15
Métrique

Résumé

Colorectal cancer is a grievous health concern, we have proved long non-coding RNA LINC00689 is considered as a potential diagnosis biomarker for colorectal cancer, and it is necessary to further investigate its upstream and downstream mechanisms.

Here, we show that KLF15, a transcription factor, exhibits the reduced expression in colorectal cancer.

KLF15 suppresses the proliferative and metastatic capacities of colorectal cancer cells both in vitro and in vivo by transcriptionally activating LINC00689 .

Subsequently, LINC00689 recruits PTBP1 protein to enhance the stability of LATS2 mRNA in the cytoplasm.

This stabilization causes the suppression of the YAP1/β-catenin pathway and its target downstream genes.

Our findings highlight a regulatory network involving KLF15, LINC00689 , PTBP1, LATS2 , and the YAP1/β-catenin pathway in colorectal cancer, shedding light on potential therapeutic targets for colorectal cancer therapy.

KLF15 transcriptionally activates LINC00689 , leading to the stabilization of LATS2 mRNA by recruiting PTBP1, which in turn suppresses colorectal tumorigenesis by inhibiting oncogenes like YAP1 and β-catenin.

Cao, Yan,Li, Jian,Zhang, Gang,Fang, Hao,Du, Yongliang,Liang, Yan, 2024, KLF15 transcriptionally activates LINC00689 to inhibit colorectal cancer development, Nature

Document

Ouvrir

Partager

Source

Articles recommandés par ES/IODE IA

Use of ileostomy versus colostomy as a bridge to surgery in left-sided obstructive colon cancer: retrospective cohort study
deviating 0 versus surgery bridge colon study left-sided obstructive stoma colostomy cancer cent